The goal of Dr. Bunimovich’s research program is to investigate the mechanisms of tumorigenesis and immune escape of melanoma and non-melanoma skin cancer (NMSC). The major effort is centered on the development of new medical technologies and therapeutics for cutaneous malignancies. In close collaboration with immunologists, chemists and other clinicians, Dr. Bunimovich is developing novel topical immunotherapy to treat high risk primary melanoma and NMSC. He is also investigating the factors leading to cutaneous microenvironment which supports tumor initiation and progression.
